Pfizer, the decline slows
Pfizer climbs 3.6% as the double bottom in the 24 area holds for a third week
Pfizer, the decline slows
Our view last week
Pfizer shares form a double bottom in the 24 area for the second week running, with buying volume steady at 70% despite a 0.6% dip. Money flow, which bottomed two weeks ago, has climbed steadily back to a hair's breadth from zero: selling pressure is fading. The Sell signal, now in its 10th week of management, remains in profit for the short.
This week's summary
Pfizer confirms its double bottom in the 24 area for a third straight week, and this time the bounce has teeth: up 3.6%, with the weekly RSI climbing to 45. The bigger tell comes from money flow, which after weeks in the red has crossed back above zero and turned positive — sellers are giving ground to buyers. The Sell signal, under management for 11 weeks now, stays only marginally in profit for the short.
IQS Phase
78
in tension
Signal Strength
2
decline fading out
Sizing
MINIMUM
Ranking
#131 / 140
US stocks
Trade P&L %
+2.45%
from signal to today
restricted Platinum content